1295674

Jason A. Ohayon, MD — FEI 3016969494

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 12, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hamilton (Canada)

Additional Details

Clinical BA/BE